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Abstract—This paper considers two types of protein data. 
First, data about protein function described in a number of 
ways, such as, GO terms and PFAM families. Second, data 
about whether individual proteins are experimentally 
associated with cancer by an anomalous elevation or lowering 
of their expressions within cancerous cells. We combine these 
two types of protein data and test whether the first type of data, 
that is, the functional descriptors, can predict the second type 
of data, that is, cancer-relatedness. By using data mining and 
machine learning, we derive a classifier algorithm that using 
only GO term and PFAM family descriptions of a protein can 
predict with over 73 percent accuracy whether it is associated 
with pancreatic cancer.  
 
Keywords—data mining, GO term, pancreatic cancer, 
PFAM family, protein. 
I. INTRODUCTION 
Data mining is increasingly applied to non-relational 
databases, including genome and protein databases [1]--[5]. 
Data mining and data classification methods are developed for 
protein structure and function [6]--[8], protein evolution [9], 
[10], protein interaction networks [11], and medical data that 
may include genomes or proteins [12]--[14]. In the present 
paper, preliminary versions of which were presented in [15] 
and [16], we focus on a pancreatic cancer protein database.  
This database was collected by Robert Powers and Bradley 
Worley, in the Department of Chemistry at the University of 
Nebraska-Lincoln, based on earlier pancreatic cancer research 
[17]--[23].  
Pancreatic cancer was chosen as a test case because it has 
the lowest survival rate among different types of cancer. Data 
mining was used to investigate the relationship among 
anomalous proteins, which have unusually high or low levels 
in pancreatic patients. Early recognition of some patterns 
developing among these anomalous proteins may allow 
treatment to start earlier and increase the survival rate of 
pancreatic cancer patients.  
Data mining of protein databases poses special challenges 
because many protein databases often contain set data types, 
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whereas most data mining and machine learning algorithms 
assume relational database inputs. We overcame this problem 
by describing effecting ways to restructure the protein 
databases into relational databases. The restructured databases 
allowed the use of several types of classifiers, such as, Support 
Vector Machines (SVMs) and decision trees. Other types of 
data mining algorithms could be also used, but we chose these 
two types because they are currently the most frequently used 
data mining methods.  
This paper is organized as follows. Section II describes 
some basic background.  Section III presents the experimental 
results of applying the J48 decision tree and the libSVM 
classifiers to the restructured pancreatic cancer database. 
Section IV gives a detailed analysis of the prostaglandin 
protein synthesis network.  Section V discusses the results. 
Finally, Section VI gives our conclusions and possible 
directions for future work. 
II. BACKGROUND CONCEPTS AND TOOLS 
In this section, part A gives an introduction to classifiers 
and part B describes the WEKA system that contains a library 
of implemented classifiers. 
A. Classifiers 
Let R(x1,…,xn, y) be a relation, where the set of attributes X 
= {x1,…,xn} is called the feature space and the y attribute is 
called a label. Each tuple of the relation describes some entity 
based on specific values of the feature space and the label.  For 
example, each row may describe a protein with specific feature 
attributes, such as, molecular weight, amino acid sequence 
etc., and a label attribute, such as, whether it is involved in 
pancreatic cancer.  
Given such a relation R, a classifier is mapping from X to y. 
If a classifier is correct on all tuples of relation R, then the 
value of y can be always predicted from the values of X.  In 
practice, the classifier may not be correct on all proteins. 
Further, classifiers are intended to be able to classify even 
those proteins that are new, not just those that are already in R. 
Popular classifiers include decision trees and Support Vector 
Machines (SVMs). A decision tree is a tree which is read from 
the root towards the leaves, and whose internal nodes are tests 
and whose leaf nodes are categories [24].  For example, C4.5 
is a well-known decision tree algorithm [25]. SVMs perform 
classification by constructing for relation R an n-dimensional 
hyperplane that optimally separates the data into two 
categories (for example when y = 0 and y = 1).  An example of 
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SVM is the libSVM implementation [26]. 
B. The WEKA Library 
In our experiments we used the Waikato Environment for 
Knowledge Analysis (WEKA) system developed at the 
University of Waikato [27], [28]. WEKA provides an 
extensive library of data mining and machine learning 
algorithms. In WEKA, the input data is a relation or table 
which is represented by an Attributes Relation File Format 
(ARFF) file. Each ARFF file starts with a title to let the user 
know what kind of data is stored in the file. The title is 
followed by a relation type and then all the attributes and their 
types. Finally, the attribute declarations are followed by the 
actual data rows.  
C. The Restructuring Method in Theory 
In the pancreatic protein database collection of about eighty 
tables, we chose for our study the GO_np and PFAM_np 
tables, which contain data about pancreatic proteins that are 
not involved in cancer, and the GO_pdac and PFAM_pdac 
tables, which contain data about pancreatic proteins that are 
related to pancreatic cancer. GO_np had 70,331, PFAM_np 
had 7,054, GO_pdac had 30,888, and PFAM_pdac had 7,272 
rows, that is, a total number of 115,545 rows. A simplified 
version of the GO_pdac looks as follows:  
 
Table 1 The GO_pdac table. 
 
UID GO 
O43491 GO:0003779 
O43491 GO:0005198 
O43491 GO:0005886 
O43491 GO:0008091 
O43491 GO:0019898 
O43491 GO:0030866 
Q96C24 GO:0005215 
Q96C24 GO:0005886 
Q96C24 GO:0019898 
Q96C24 GO:0030658 
Q96C24 GO:0042043 
… … 
 
                   
The GO_pdac table lists all (UID, GO) pairs, such that UID 
is the universal identifier of a pancreatic protein and GO is a 
feature descriptor, also called a GO term.  The UID and the 
GO terms can be found in the UNIPROT database 
(www.uniprot.org). There is a many-to-many relationship 
between the UIDs and the GO terms.  For example, rows three 
and five with the same UID O43491 are related to two 
different GO terms, GO:0005886 and GO:0019898.  On the 
other hand, rows three and eight with the same GO term 
GO:0005886 are related to two different UIDs, O43491 and 
Q96C24.  
 
The GO_np tables listed (UID, GO) pairs of non-pancreatic 
proteins. We merged the GO_np and GO_pdac tables without 
losing the information whether the protein is related to cancer 
or not. Hence we extended the GO_np and the GO_pdac tables 
with a Y column, which denotes whether the protein is related 
to pancreatic cancer or not. All the proteins in the GO_np table 
are extended with a Y value of "0", while all the proteins in the 
GO_pdac table are extended with a Y value of "1" by the 
following SQL query, which we call SQL 1 in Fig. 1: 
 
create view GO_merge (UID, GO, Y) as 
select UID, GO, 0 from GO_np  
union 
select UID, GO, 1 from GO_pdac; 
 
After the above query is executed the GO_merge table looks 
as follows: 
Table 2 The GO_merge table. 
 
UID GO Y 
O43491 GO:0003779 1 
O43491 GO:0005198 1 
O43491 GO:0005886 1 
O43491 GO:0008091 1 
O43491 GO:0019898 1 
O43491 GO:0030866 1 
Q96C24 GO:0005215 1 
Q96C24 GO:0005886 1 
Q96C24 GO:0019898 1 
Q96C24 GO:0030658 1 
Q96C24 GO:0042043 1 
… … … 
 
We restructured or “flattened” the above table by an SQL 
query that transformed GO_merge into another table 
GO_merge_flat in which all information about a single protein 
appears in one row, as shown in Table 3. 
 
Table 3 The GO_merge_flat table. 
 
UID 0
0
0
3
7
7
9 
0
0
0
5
1
9
8 
0
0
0
5
2
1
5 
0
0
0
5
8
8
6 
0
0
0
8
0
9
1 
0
0
1
9
8
9
8 
0
0
3
0
8
6
6 
Y 
O43491 1 1 0 1 1 1 1 1 
Q96C24 0 0 1 1 0 1 0 1 
 
In theory, the number of attributes in the restructured 
relation is n+2, where n is the number of distinct GO terms. 
Apart from UID and Y, these distinct GO terms form the 
attributes of the restructured relation. Below each GO term a 
‘1’ or ‘0’ indicates whether the GO term applies to the protein 
indicated by the UID on the left.  
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D. Simplifying the Restructuring Problem   
 
The restructuring method described in the part C is not 
practical because it requires a huge matrix. For example, since 
GO_merge table contains 17943 distinct UIDs and 7935 
distinct GO terms, a straightforward application of the 
restructuring method would yield a table with  
 
17943 x (7935 + 2) ≈ 1.6 x 108 
 
entries. The WEKA and other machine learning systems 
simply cannot handle such big matrices. Moreover, the matrix 
could become even bigger when we consider not only GO 
terms but PFAM families and other attributes as described in 
part E below. 
 One possible way to reduce the size of the matrix is using 
Principal Component Analysis.  Using Principal Component 
Analysis, the matrix could be rewritten into another matrix 
with a smaller number of columns. The new columns would be 
linear combinations of the existing columns, that is, the 7935 
GO terms.  While this would reduce the size of the matrix and 
alleviate the runtime problems with WEKA and other machine 
learning systems, it would still not be a good solution.  
Our ultimate goal is to be able to easily and accurately 
identify whether a new protein may be associated with cancer. 
Intuitively, we would like to characterize the cancer-related 
proteins based only on a small subset of the GO terms because 
it is impractical to test each of the 7935 GO terms whether it 
applies to a new protein. The Principal Component Analysis 
would still require that we test each of the 7935 GO terms, and 
then linearly combine their (1 or 0) values to find the new 
columns. That is why the Principal Component Analysis would 
not yield a satisfying solution.  
We need another method to find a small subset of the GO 
terms that characterizes the proteins in terms of cancer-
relatedness as accurately as the entire set of GO terms would 
characterize those. How can we find such a subset of the GO 
terms?   
Luckily, the restructuring matrix would be very sparse 
because most of the UIDs are characterized by less than ten 
GO terms. Hence most of the 7935 distinct GO terms would 
have a value of 0 in most rows. GO terms that occur only 
rarely do not connect many different UIDs hence they are not 
very useful as efficient cancer indicators.   
 Hence we experimented with selecting only the top n most 
frequent GO terms. We observed that in general when n 
increases the accuracy also increases. At some point the 
increase in the accuracy diminishes with further increments in 
n. Hence it is not worth to increase further the value of n 
beyond that point. In our case, this value of n was about 200. 
Therefore, in the experiments presented below we selected 
only the top 200 most frequent GO terms as follows. First we 
found the frequency of each Go terms using the following SQL 
query: 
 
create view GOcount(GO,count) as  
select GO, count(*)  
from GO_merge 
group by GO; 
 
The new table GOcount(GO,count) contains the count of 
each GO term. We extracted the top 200 most frequent GO 
terms into a text file as follows:  
 
select GO from GOcount 
order by count desc limit 200 
into outfile `/tmp/MergeTop200GO.txt'; 
 
We wrote a C++ program, which is shown in detail in the 
APPENDIX, to automatically generate the restructuring SQL 
query. Apart from some initialization and ending, the program 
repeatedly reads the next GO term from the input file 
MergeTop200GO.txt and writes to an output file 
SQL_flatten.txt the line of the SQL query that corresponds to 
the GO term. Below is how the SQL_flatten.txt file looks like.   
  
select UID, 
max(case when GO = `GO:0016021' then 1 else 0 end) as 
`GO:0016021', 
max(case when GO = `GO:0005515' then 1 else 0 end) as 
`GO:0005515', 
max(case when GO = `GO:0005634' then 1 else 0 end) as 
`GO:0005634', 
max(case when GO = `GO:0005737' then 1 else 0 end) as 
`GO:0005737', 
max(case when GO = `GO:0008270' then 1 else 0 end) as 
`GO:0008270', 
max(case when GO = `GO:0006350' then 1 else 0 end) as 
`GO:0006350', 
max(case when GO = `GO:0007165' then 1 else 0 end) as 
`GO:0007165', 
max(case when GO = `GO:0005886' then 1 else 0 end) as 
`GO:0005886', 
max(case when GO = `GO:0005524' then 1 else 0 end) as 
`GO:0005524', 
max(case when GO = `GO:0003677' then 1 else 0 end) as 
`GO:0003677', 
…  
Y 
from GO_merge 
group by UID 
 
When the above SQL query is executed, for each UID it 
checks all the GO terms. If any of the GO terms the UID is 
associated with matches a particular GO term for which we are 
creating a column in the flattened table, then that GO term will 
get a value of ``1" else it will get a value of ``0". The process 
then continues until it does not read any more UID groups. 
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E. Merging GO_merge and PFAM_merge 
 
The PFAM table is similar to the GO table. The PFAM 
table contains the UID of proteins and the PFAM terms, which 
form another set of characterizations of proteins as an 
alternative to the GO term characterization. We can create 
PFAM_merge by merging PFAM_np and PFAM_pdac 
similarly to how we created GO_merge.  Fig. 1 outlines the 
process of merging the GO_merge and the PFAM_merge 
tables together when we need to use both the GO and the 
PFAM terms.  Table 4 is an example PFAM_merge table. The 
SQL query, called SQL 2 in Fig. 1, to generate the 
PFAM_merge table is similar to the SQL 1 query we saw 
before. 
 
                                   Fig. 1 Generating GO_PFAM_merge. 
 
Table 4 The PFAM_merge table. 
 
UID PFAM Y 
P02656 PF05778 0 
P09651 PF00076 0 
Q9BY79 PF00431 0 
Q9BY79 PF01392 0 
Q9BY79 PF00057 0 
O95931 PF00385 0 
Q9UKU0 PF00501 0 
P10323 PF00089 0 
Q17RR3 PF00151 0 
Q17RR3 PF01477 0 
… … … 
In Fig. 1, SQL 3 refers to the following query: 
  
select T.UID, 
max(case when GO = `GO:0016021' then 1 else 0 end) as 
`GO:0016021', 
… 
max(case when family = `PF07647' then 1 else 0 end) as 
`PF07647' 
… 
, T.Y 
from GO_merge T JOIN PFAM_merge ON T.UID = 
PFAM_merge.UID 
group by UID 
 
 
 
 
 
 
In our experiments, we used the top n most frequent GO terms 
as well as the top m most frequent PFAM terms, yielding a 
relation with n+m+2 attributes. We varied the values of n and 
m as described in the next section.  
III. EXPERIMENTAL RESULTS 
 
Given a flattened file, as in Table 3, it is easy to generate an 
ARFF file, which is needed for the WEKA system. In the 
ARFF file, the UID attribute ranges over strings that describe 
protein IDs, and the "relation" attribute substitutes for the "Y" 
attribute. For example, Table 3 is described using ARFF as 
follows: 
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@relation GO_merge_flat 
@attribute ``UID" {O43491, Q96C24} 
@attribute ``GO:0003779”  {0, 1} 
@attribute ``GO:0005198”  {0, 1} 
@attribute ``GO:0005215”  {0, 1} 
@attribute ``GO:0005886”  {0, 1} 
@attribute ``GO:0008091”  {0, 1} 
@attribute ``GO:0019898”  {0, 1} 
@attribute ``GO:0030866”  {0, 1} 
@attribute ``relation" {0, 1}  
@data 
``O43491",1,1,0,1,1,1,1,1 
``Q96C24",0,0,1,1,0,1,0,1 
 
From our WEKA library, we used the libSVM support 
vector machine, which was previously added to the library, 
and the J48 decision tree. Both of these accepted input in 
ARFF format. The stratified cross-validation was used in all 
our classifications.  
 
A. Support Vector Machine Results 
 
Using libSVM with the GO_merge_flat file, WEKA gave 
the following: 
 
CORRECTLY CLASSIFIED: 12947 72.156 % 
INCORRECTLY CLASSIFIED: 4996 27.844 % 
TOTAL NUMBER: 17943 100 % 
 
WEKA also gave the following confusion matrix: 
 
a b CLASSIFIED 
12794 305 a = 0 
4691 153 b = 1 
 
The confusion matrix displays the relationship between two 
or more categorical variables. The number of correctly 
classified instances is the sum of the diagonals in the confusion 
matrix; all the others are incorrectly classified. For libSVM 
with the PFAM_merge file and stratified cross-validation, the 
data mining results with were as follows: 
 
CORRECTLY CLASSIFIED: 11590 71.707 % 
INCORRECTLY CLASSIFIED: 4573 28.293 % 
TOTAL NUMBER: 16163 100 % 
 
The classification for all our instance was correct for about 
71.7 % of the instances. Below is the confusion matrix: 
 
a b CLASSIFIED 
163 4263 a = 0 
310 11427 b = 1 
 
B.  Decision Tree Results 
 
Our next set of experiments used the J48 decision tree. The 
decision tree with the GO_merge_flat file gave the following 
results: 
 
CORRECTLY CLASSIFIED: 12922 72.017 % 
INCORRECTLY CLASSIFIED: 5021 27.983 % 
TOTAL NUMBER: 17943 100 % 
 
The classification was again about 72 % correct. Below is 
the confusion matrix for the J48 decision tree: 
 
a b CLASSIFIED 
12562 537 a = 0 
4484 360 b = 1 
 
For decision tree with the PFAM_merge_flat file, the data 
mining results were as follows: 
 
CORRECTLY CLASSIFIED: 11719 72.505 % 
INCORRECTLY CLASSIFIED: 4444 27.495 % 
TOTAL NUMBER: 16163 100 % 
 
 
 The classification for all our instances was correct for over 
72 % of the instances. It was slightly better than for 
GO_merge_flat with the decision tree classification. Below is 
the confusion matrix for the PFAM_merge decision tree: 
 
a b CLASSIFIED 
144 4282 a = 0 
162 11575 b = 1 
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C. Improving the Accuracy 
 
As we saw above, for both the GO_merge_flat and the 
PFAM_merge_flat files and both the libSVM and the J48 the 
accuracy was around 72 %. A natural question is whether the 
accuracy can be improved by using both the GO terms and the 
PFAM families together. As we saw in Fig. 1, these terms can 
be combined in a relation GO_PFAM_merge. This file can be 
also flattened and represented in ARFF. We performed another 
set of experiments using WEKA and the 
GO_PFAM_merge_flat file. The results for the libSVM were 
the following: 
 
CORRECTLY CLASSIFIED: 13099 73.003 % 
INCORRECTLY CLASSIFIED: 4844 26.997 % 
TOTAL NUMBER: 17943 100 % 
 
Finally, the results for J48 were the following: 
 
CORRECTLY CLASSIFIED: 12936 72.095 % 
INCORRECTLY CLASSIFIED: 5007 27.905 % 
TOTAL NUMBER: 17943 100 % 
 
 
Our results from the GO_PFAM_merge analysis show that 
the libSVM has the highest percentage of 73 % compared to 
72 % for the decision tree. 
IV. PROSTAGLANDIN SYNTHESIS 
Several recent studies have identified prostaglandin to be a 
major factor in pancreatic cancer [29]-[31]. We retrieved from 
the UNIPROT database (www.uniprot.org) all prostaglandin-
related proteins using the following query:  
 
(prostaglandin AND organism:"Homo sapiens [9606]") 
AND reviewed:yes 
 
The query retrieved 89 proteins, but many of those were 
indicated to belong specifically to the liver, brain or other 
organs. By cross-checking with our pancreatic protein 
database, we identified the 24 pancreatic and prostaglandin-
related proteins shown in Table 5.  The prostaglandin-related 
proteins interact with each other as shown in Fig. 2. 
 
Combining all of the information in Table 5 and Fig. 2, we 
hypothesize that in pancreatic cancer the following chain of 
events takes place, where “anomaly” means either over-
expressed or under-expressed.  
Table 5. Prostaglandin-related pancreatic proteins. 
 
UID Name Y 
O15496 Group 10 secretory phospholipase A2 0 
O60733 Group VI phospholipase A2 0 
O60760 Glutathione S-transferase 0 
P02775 Platelet basic protein 1 
P04083 Phospholipase A2 inhibitory protein 1 
P08047 Transcription factor Sp1 1 
P09917 Arachidonate 5-lipoxygenase  (ALOX5) 1 
P23219 Prostaglandin H2 synthase 1(COX-1) 1 
P24557 Thromboxane-A synthase 0 
P34995 Prostaglandin E2 receptor EP1 subtype 0 
P35354 Prostaglandin G/H synthase 2 (COX-2) 0 
P35408 Prostaglandin E2 receptor EP4 subtype 1 
P41222 Prostaglandin D2 synthase 1 
P43115 Prostaglandin E2 receptor EP3 subtype 1 
P43116 Prostaglandin E2 receptor EP2 subtype 1 
P47712 Cytosolic phospholipase A2 0 
Q14684 Prostaglandin E synthase 0 
Q15185 Cytosolic prostaglandin E2 synthase 1 
Q16647 Prostacyclin synthase 0 
Q68DD2 Cytosolic phospholipase A2 zeta 0 
Q92959 Prostaglandin transporter 1 
Q9H7Z7 Prostaglandin E synthase 2 0 
Q9NP80 Ca-independent phospholipase A2-gamma 1 
Q9P2B2 Prostaglandin F2-alpha receptor regulator 1 
 
 
 
Fig. 2 Prostaglandin synthesis [32] 
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1. Phospholipase A2 (Q9NP80) anomaly. 
2. Arachidonic acid anomaly. 
a. COX-1 (P23219) and Prostaglandin H2 
anomalies. 
i. Prostaglandin D2 synthase (P41222) 
anomaly. 
ii. Prostaglandin E2 receptors EP2 
(P43116), EP3 (P43115), and EP4 
(P35408), Prostaglandin E2 
synthase (Q15185), and 
Prostaglandin F2-alpha receptor 
regulator (Q9P2B2) anomalies. 
b. ALOX5 (P09917) anomaly. 
 
 
Due to various feedback loops, anomalies at some point in a 
chain may be compensated. In pancreatic cancer, we do not 
see further anomalies in the right-side chain of Fig. 2 starting 
with HPETE because Glutathione S-transferase (O60760) is 
not elevated. Similarly, we have little evidence for anomaly in 
the two other branches starting from Prostaglandin H2 because 
neither Prostacyclin synthase (Q16647) nor Thromboxane-A 
synthase (P24557) is anomalous. Hence the hypothetical 
process of pancreatic cancer can be summarized as follows: 
 
 Q9NP80 → P23219 → P41222 
                         ↓ 
                    Q15185 → Q9P2B2 
 
V. DISCUSSION OF THE RESULTS 
 
The results reveal that the characterizations of the 
pancreatic proteins by either GO terms or PFAM families can 
be used to predict with a good, that is, around 72 %, accuracy 
whether they are involved in cancer. Since the characterization 
of proteins is mainly based on their biological functions, the 
results imply that the likelihood of a protein being involved in 
cancer depends on its particular functions. Although the 72 % 
accuracy is interesting, for medical applications a higher, over 
90 %, accuracy would be necessary. It is not clear how that 
higher accuracy could be achieved. Our second set of 
experiments with both GO terms and PFAM families together 
gave a slight increase in accuracy to 73 % in the case of 
libSVM. It is possible that by adding even more protein 
attributes, the accuracy of classification would improve 
further.  
It appears that proteins involved in certain general functions 
or particular protein networks within cells are more likely to 
be associated with cancer. It appears that within these 
particular protein synthesis networks entire pathways may be 
predisposed to anomalous behavior and cause cancer. In 
particular, we gave an in-depth study of the prostaglandin 
protein synthesis network. We are not aware of any previous 
work that called attention to the identified pathways starting 
from Q9NP80, although the anomalous behavior of Q9NP80 
may be traced further back in an expanded network.  
VI. CONCLUSION 
Further study is needed to develop an early detection 
method for pancreatic cancer, enabling earlier treatment of 
cancer patients, and thereby increase their survival rate, which 
is currently one of the lowest among cancer patients.  
The result that the functional characterizations of proteins 
by either GO terms or PFAM families enable a good 
prediction of pancreatic cancer link may be also generalized to 
other types of cancers. The putative role of Q9NP80 in the 
early stages of pancreatic cancer should be further 
investigated.  
APPENDIX 
Below is the C++ program which helps us to generate 
automatically the written SQL queries that are used for data 
restructuring: 
 
#include <iostream> 
#include <fstream> 
#include <string> 
 
using namespace std; 
 
int main() 
{ 
string line; 
 
ifstream ifs("MergeTop200GO.txt"); 
ofstream myfile ("SQL_flatten.txt", ios::app); 
 
if (ifs.good())                        // If opening is successful 
{ 
myfile "select UID , \n";   // output the first line 
        
 while(getline(ifs,line))      // read each line until EOL 
{ 
myfile >> "max(case when GO = \" >> line >> 
           "\ then 1 else 0 end) as \" >> line >> "\," >> endl; 
        }                                        // end-while  
 
myfile  >> "Y \ n"; 
myfile  >> "from GO_merge \n";  
myfile  >> "group by UID \n"; 
myfile.close(); 
ifs.close();                      // close the file 
}  
else 
cout  >> "ERROR: can't open file!!!" >> endl; 
return 0; 
} 
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